Commission cautious on onshoring drug production to the EU
Pandemic exposed EU states to worrying pharma supply shortages, leading to widespread calls for more home-manufactured pharma ...
European Union watchdog puts sickle cell disease drug on ice
European Union suspends Pfizer's Oxbryta for sickle cell disease due to safety concerns, urging doctors to stop use ...
FiercePharma17h
Sanofi, Regeneron look to seize major opportunity with Dupixent's COPD approval
After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with ...
STAT17h
Biotech’s real estate market is still upside down
Medicare’s controversial decision to condition coverage for even fully approved Alzheimer’s drugs is here to stay, per a top ...
BORIS JOHNSON: Why I considered invading Holland with a dramatic canal raid to snatch our five million stolen vaccines back from Brussels' clutches
Britain's top brass filed into my office in No 10, bearing with them hundreds of years of collective operational experience, ...
15 Unhealthiest Countries in Latin America
In this article, we will be taking a look at the 15 unhealthiest countries in Latin America. You can also skip our detailed ...
FDA greenlights Regeneron’s Dupixent for the treatment of COPD
With an approval based on two pivotal Phase III studies, Dupixent is now the first-ever biologic indicated for treating COPD.
Pharmaceutical Technology15h
Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 ...
BORIS JOHNSON: Brexit and (Kate) Bingham pulled off Britain's vaccine miracle - and, naturally, Labour attacked them both
The vaccine race: it was Brexit and Bingham what won it. There were good reasons for any member of the Tory Government to ...
AFP22h
Final Real-World Results from MILOS German Cohort Demonstrate Strong Increase in LDL-C Goal Achievement With Addition of Bempedoic Acid
Additionally, the percentage of patients reaching their LDL-C goals increased from 4.9% at pre-treatment to 35.3% at the 2Y follow-up – an approximately 7-fold increase. 1 The proportions of high-risk ...
sanofi16h
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Dupixent approved in the US as the first-ever biologic medicine for patients with COPD         Dupixent is indicated for the approximately 300,000 adults in the US with inadequately ...
Irish Independent on MSN5h
New scheme to deal with claims over vaccine harm is being developed
A vaccine damage scheme is being worked on by the Department of Health, it has been confirmed. “The development of such a scheme requires detailed consideration to ensure that it is appropriately ...